• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Jay L. Patel, MD, MBA

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English

Dr. Patel is an associate professor of pathology at the University of Utah School of Medicine. In addition, Dr. Patel serves as Executive Director of Clinical Trials & PharmaDx at ARUP Laboratories. He received his MD from the University of Arizona and completed a residency in anatomic and clinical pathology at the University of Utah. Dr. Patel then served as a hematopathology fellow at Stanford University. He is certified by the American Board of Pathology in anatomic and clinical pathology, with subspecialty boards in hematology. Dr. Patel’s clinical and research interests are broad and include all aspects of hematopathology. He is keen on application of next-generation sequencing technologies in the diagnosis and prognostication of hematolymphoid malignancies and benign hematologic disorders.

Specialties

  • Hematopathology
  • Pathology, Anatomical
  • Pathology, Clinical

Board Certification and Academic Information

Academic Departments Pathology - Associate Professor (Clinical)
Academic Divisions Clinical Pathology
Board Certification American Board of Pathology (Anatomic & Clinical)
American Board of Pathology (Sub: Hematology)

Dr. Patel is an associate professor of pathology at the University of Utah School of Medicine. In addition, Dr. Patel serves as Executive Director of Clinical Trials & PharmaDx at ARUP Laboratories. He received his MD from the University of Arizona and completed a residency in anatomic and clinical pathology at the University of Utah. Dr. Patel then served as a hematopathology fellow at Stanford University. He is certified by the American Board of Pathology in anatomic and clinical pathology, with subspecialty boards in hematology. Dr. Patel’s clinical and research interests are broad and include all aspects of hematopathology. He is keen on application of next-generation sequencing technologies in the diagnosis and prognostication of hematolymphoid malignancies and benign hematologic disorders.

Academic Locations

Board Certification and Academic Information

Academic Departments Pathology - Associate Professor (Clinical)
Academic Divisions Clinical Pathology
Board Certification American Board of Pathology (Anatomic & Clinical)
American Board of Pathology (Sub: Hematology)

Education History

Graduate Training University of Utah
Business Management
M.B.A., 2018
Fellowship Stanford University
Hematopathology
Fellow, 2011
Residency University of Utah
Anatomic and Clinical Pathology
Resident, 2010
Professional Medical University of Arizona
Medicine
M.D., 2006
Undergraduate University of Arizona
Molecular & Cellular Biology
B.S., 2002

Selected Publications - Journal Articles

Journal Article

  1. Sande CM, Wu R, Yang G, Sussman RT, Bigdeli A, Rushton C, Chitturi A, Patel J, Szankasi P, Morrissette JJD, Lim MS, Elenitoba-Johnson KSJ (2022). Rapid and Automated Semiconductor-Based Next-Generation Sequencing for Simultaneous Detection of Somatic DNA and RNA Aberrations in Myeloid Neoplasms. J Mol Diagn.
  2. Li P, Brown S, Williams M, White TA, Xie W, Cui W, Peker D, Lei L, Kunder CA, Wang HY, Murray SS, Vagher J, Kovacsovics T, Patel JL (2022). The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms. Blood, 140, 716-755.
  3. Hu B, Patel JL, Tao R, Cannon RB, Monroe M, Goyal G (2022). Near Complete Response to Trametinib Treatment in Histiocytic Sarcoma Harboring a Somatic KRAS Mutation. J Natl Compr Canc Netw, 1-4.
  4. Li P, White T, Xie W, Cui W, Peker D, Zeng G, Wang HY, Vagher J, Brown S, Williams M, Kovacsovics T, Patel JL (2021). AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome. Leukemia, 36, 664-674.
  5. Osman A, Patel JL (2021). Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis. Clin Chem, 67, 1062-1070.
  6. Patel JL, Abedi M, Cogle CR, Erba HP, Foucar K, Garcia-Manero G, Grinblatt DL, Komrokji RS, Kurtin SE, Maciejewski JP, Pollyea DA, Revicki DA, Roboz GJ, Savona MR, Scott BL, Sekeres MA, Steensma DP, Thompson MA, Dawn Flick E, Kiselev P, Louis CU, Nifenecker M, Swern AS, George TI (2020). Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes. Int J Lab Hematol, 43(3), 426-432.
  7. Sireci AN, Patel JL, Joseph L, Hiemenz MC, Rosca OC, Caughron SK, Thibault-Sennett SA, Burke TL, Aisner DL (2020). *Denotes equal contribution. Molecular Pathology Economics 101: An Overview of Molecular Diagnostics Coding, Coverage, and Reimbursement: A Report of the Association for Molecular Pathology. J Mol Diagn, 22(8), 975-993.
  8. Mansoor A, Mansoor MO, Patel JL, Zhao S, Natkunam Y, Bieker JJ (2020). KLF1/EKLF expression in acute leukemia is correlated with chromosomal abnormalities. Blood Cells Mol Dis, 83, 102434.
  9. Schumacher JA, Holgard VD, Sial F, Pearson LN, Patel JL, Karner KH (2019). Detection and Quantification of FLT3 Internal Tandem Duplication Mutations Do Not Vary Significantly Between Whole Blood and Blast-Enriched Samples. Am J Clin Pathol, 153(2), 251-257.
  10. Karner K, George TI, Patel JL (2019). Current Aspects of Clonal Hematopoiesis: Implications for Clinical Diagnosis. Ann Lab Med, 39(6), 509-514.
  11. Cessna MH, Paulraj P, Hilton B, Sadre-Bazzaz K, Szankasi P, Cluff A, Patel JL, Hoda D, Toydemir RM (2019). Chronic myelomonocytic leukemia with ETV6-ABL1 rearrangement and SMC1A mutation. Cancer Genet, 238, 31-36.
  12. Corean JLE, George TI, Patel JL, Li KD (2019). Bone marrow findings in metastatic melanoma, including role of BRAF immunohistochemistry. Int J Lab Hematol, 41(4), 550-560.
  13. Shen W, Paxton CN, Szankasi P, Longhurst M, Schumacher JA, Frizzell KA, Sorrells SM, Clayton AL, Jattani RP, Patel JL, Toydemir R, Kelley TW, Xu X (2017). Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing. J Clin Pathol, 71(4), 372-378.
  14. Sangle NA, Schmidt RL, Patel JL, Medeiros LJ, Agarwal AM, Perkins SL, Salama ME (2014). Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm. Mod Pathol, 27(8), 1137-43.

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Price Estimate
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

Appointment Scheduling:
801-213-9500

Hospital Operator:
801-581-2121

En Español:
801-646-5914

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2023 University of Utah Health